Japan Drug Makers See Rising Overseas Sales Ratio amid Uphill Battle at Home: Tally

Combined sales of 27 Japanese drug makers rose 3.3% year on year in FY2017, with companies deriving increasing proportions of their revenues from overseas markets, illustrating a tough business environment at home, a Jiho tally shows. The tally covered 27...read more